Findings seen for patients with drug-resistant temporal lobe epilepsy
MONDAY, April 14, 2025 (HealthDay News) — Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy, according to a study published online March 6 in Cureus.
In a prospective cohort interventional study conducted in Egypt between 2022 and 2024, Sameh M. Salama, Ph.D., from the Al-Azhar University of Medicine in Cairo, and colleagues assessed epilepsy control after medial temporal lobectomy (with or without amygdalohippocampectomy) for management of drug-resistant temporal lobe epilepsy. Postoperative seizure control was evaluated using the Engel classification scale during follow-up and withdrawal of antiepileptic drugs.
The researchers found that seizure control improved after medial temporal lobectomy. At final follow-up, 15 respondents (75 percent) reached Engel class I (no seizures) and five respondents (25 percent) reached Engel class II (rare, nondisabling seizures).
“These results support surgical management as an essential treatment option for medically refractory epilepsy and highlight the importance of identifying patients for early surgical evaluation,” Salama and colleagues conclude. “More studies with bigger sample sizes along with extended follow-up periods should be performed to improve patient selection criteria and surgical methods that enhance patient outcomes.”
Cast Immobilization Noninferior to Surgery for Weber B Ankle Fracture 
Prevalence of Medications for Opioid Use Disorder on the Rise in U.S. Adults Undergoing Surgery 
Online Intervention Can Reduce Sleep Onset Latency in Children With Epilepsy 
Varenicline Can Cut Cannabis Use Among Men With Cannabis Use Disorder 
More Than One in Four Adults Eligible for GLP-1 Receptor Agonists 
Smartphone Apps May Boost Smoking Cessation 
IV Iron Dextran Cost-Effective for Managing Iron-Deficiency Anemia 
